fda and tirzepatide approval for Zepbound (tirzepatide) injection, the first only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA accepts generic tirzepatide bids
Description
GLP-1 receptor agonists are the most talked-about drug class in medicine right now
Drugmaker Novo Nordisk announces they are expanding access to its weight loss drug WeGovy with a new partnership with Weight Watchers.
Not for human consumption or diagnostic use
However, medical supervision is crucial, and lifestyle changes complement its benefits.
New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related diseases.
